 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Mark Nehler and Cecilia Low Wang.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.169 |
|
|
|
-
Hogan SE, Canonico ME, King RW, Low Wang CC, Nehler MR, Parr J, Rogers RK, Lu W, Albanese J, Barnathan ES, Spyropoulos AC, Douketis JD, Bonaca MP, Capell WH. Preserving Trial Endpoint Specificity and Cause of Death Attribution in Cardiovascular Trials: Insights From MARINER. JACC Adv. 2025 May 12; 4(6 Pt 1):101763.
Score: 0.062
-
Canonico ME, Low Wang CC, Hsia J, Debus ES, Nehler MR, Patel MR, Anand SS, Ycas J, Capell WH, Muehlhofer E, Haskell LP, Berkowitz SD, Bauersachs R, Bonaca MP. Low-Dose Rivaroxaban Plus Aspirin in?Fragile Patients After Lower Extremity?Revascularization. J Am Coll Cardiol. 2024 Aug 27; 84(9):801-811.
Score: 0.059
-
Govsyeyev N, Nehler MR, Low Wang CC, Kavanagh S, Hiatt WR, Long C, Jones WS, Fowkes FGR, Berger JS, Baumgartner I, Patel MR, Goodney PP, Beckman JA, Katona BG, Mahaffey KW, Blomster J, Norgren L, Bonaca MP. Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial. J Vasc Surg. 2022 02; 75(2):660-670.e3.
Score: 0.048
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|